Business Context and Reporting Period
This Form 6-K filing by ImmunoPrecise Antibodies Ltd. (not Mindwalk Holdings Corp.) covers a material change report dated September 22, 2023, for the month of September 2023. The registrant is a foreign private issuer based in Victoria, British Columbia, and files annual reports on Form 40-F.
Key Financial Metrics
The filing text provided does not contain specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document serves as a cover sheet incorporating a Material Change Report by reference.
Material Changes
The filing indicates the existence of a Material Change Report dated September 22, 2023 (Exhibit 99.1), but the specific details of the change are not included in the provided text. The report is incorporated by reference into Registration Statements on Form F-3 and Form S-8.
Guidance, Outlook, and Risks
The provided text does not include management commentary, financial guidance, outlook, specific risks, contingencies, or unusual items. These details are expected to be contained within the referenced Exhibit 99.1.
Investor Verification Checklist
- Verify the specific content of the Material Change Report (Exhibit 99.1) referenced in this filing.
- Confirm the discrepancy between the requested company name (Mindwalk Holdings Corp.) and the actual registrant (ImmunoPrecise Antibodies Ltd.).
- Review the referenced Registration Statements (File No. 333-273197 and 333-256730) for context on the material change.
- Check subsequent filings for any financial updates related to the material change reported on September 22, 2023.